Formulary Monographs [IPRATROPIUM|SALBUTAMOL, 4892]
|
|
IPRATROPIUM | SALBUTAMOL
|
|
|
|
|
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
Treating moderate-to-severe COPD; it is indicated primarily in
patients who fail to resp ond on ipratropium alone. The role of the combination in acute asthma is unclear. |
|
|
Tachycardia, dry mouth, Bronchitis, upper respiratory tract infections and headache.
|
|
|
Two inhalations four times daily is indicated in chronic obstructive pulmonary disease. In severe acute asthma, ipratropium 0.5mg/salbutamol 2.5mg via nebulizer has been administered. See
BDS supply protocols pg. 10. |
|
|
|
|
|
|
|
|
|
|
|
|